Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evaluation of ExoDx™ Prostate(IntelliScore) in Men Presenting for Initial Prostate Biopsy

NCT04720599 is registered in ClinicalTrials.gov with Exosome Diagnostics, Inc. as lead sponsor.

NCT NCT04720599
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04720599 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evaluation of ExoDx™ Prostate(IntelliScore) in Men Presenting for Initial Prostate Biopsy
Lead sponsor
Exosome Diagnostics, Inc.
Phase
Observational
Overall status
Completed
Start date
June 1, 2020
Completion date
June 1, 2021
Enrollment
120 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

urologic cancer